MedTrace Logo

Effects of the Nottingham Augmented Reality (AR) App for Arthritis Hand Joint Pain

NCT05634291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-07-25

No results posted yet for this study

Summary

The aim of this run-in design, feasibility study is to assess outcomes (including opioid-use, pain intensity, emotional function, and general physical function) for an augmented reality illusion therapy in participants with chronic hand joint pain due to arthritis.

Conditions

Interventions

OTHER

Standard of care

Standard of care as prescribed by healthcare provider.

DEVICE

Nottingham AR smartphone app with active intervention

AR software treatment delivered by smartphone app and developed by VRx Medical (VRx) using established principles of illusion therapies (e.g. mirror therapy) for pain management.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • San Diego Veterans Healthcare System

    collaborator FED

  • VRx Medical Inc

    lead INDUSTRY

Principal Investigators

  • Thomas Rutledge, PhD · San Diego Veterans Healthcare System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2023-06-16
Completion
2023-07-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05634291 on ClinicalTrials.gov